Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€226.00
30.09.23
-
30.09.24
-15.49%
14.10.23

buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.11
27.09.23
€4.00
27.09.24
5.76%
23.11.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.12
27.09.23
-
27.09.24
-35.70%
30.09.23

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.54
26.09.23
-
26.09.24
20.23%
27.09.23

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.47
26.09.23
-
26.09.24
-26.87%
15.10.23

Could be very worthwhile Investment >20% year
buy
Sientra Inc.

Start price
Target price
Perf. (%)
€2.52
25.09.23
€5.20
25.09.24
-23.41%
11.10.23

Could be very worthwhile Investment >20% year
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.76
19.09.23
€6.00
19.09.24
-1.68%
30.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
MicroVision Inc

Start price
Target price
Perf. (%)
€2.02
19.09.23
€4.00
19.09.24
4.43%
27.09.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Cytosorbents Corp.

Start price
Target price
Perf. (%)
€1.83
17.09.23
-
17.09.24
-52.14%
19.01.24

Probably not worthwhile Investment
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€20.12
16.09.23
-
16.10.23
-10.64%
17.10.23

Vitrolife AB

Start price
Target price
Perf. (%)
€12.54
16.09.23
€6.00
16.09.24
2.47%
30.09.23

buy
Orpea Nom.

Start price
Target price
Perf. (%)
€1.32
08.09.23
-
08.09.24
10.08%
15.09.23

Could be very worthwhile Investment >20% year
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€4.79
07.09.23
-
07.09.24
-4.59%
16.09.23

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
GN Store Nord A/S

Start price
Target price
Perf. (%)
€17.36
05.09.23
-
05.09.24
5.53%
16.09.23

buy
Gerresheimer AG

Start price
Target price
Perf. (%)
€122.70
04.09.23
-
04.10.23
-14.91%
12.09.23

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.01
03.09.23
-
03.09.24
-19.80%
05.11.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.67
02.09.23
€17.00
02.09.24
-5.50%
16.09.23

Coloplast A/S B

Start price
Target price
Perf. (%)
€104.50
02.09.23
-
02.09.24
-0.38%
16.09.23

buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€354.20
29.08.23
€450.00
29.08.24
-35.43%
25.10.23

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€29.39
25.08.23
-
25.08.24
0.20%
02.09.23

ifa systems AG

Start price
Target price
Perf. (%)
€3.16
20.08.23
€0.000
20.08.24
-5.70%
03.09.23

Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€248.20
19.08.23
-
19.08.24
5.40%
02.09.23

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€30.17
11.08.23
-
11.08.24
-3.38%
19.08.23

buy
T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€0.28
08.08.23
€1.00
08.02.24
-41.28%
08.02.24

Tabula Rasa HealthCare Inc

Start price
Target price
Perf. (%)
€9.35
08.08.23
-
08.08.24
5.88%
11.12.23

Probably not worthwhile Investment